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S U M M A R Y
Granulomatous diseases are common in HIV-infected patients and are usually related to opportunistic
infectious or tumoral conditions. We report three cases of uncommon granulomatous disease in HIV-
infected patients who had previously received silicone and for which diagnostic investigations remained
negative.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Silicone has been widely used in esthetic and reconstructive
surgery since the early 1960s.1 Local and systemic granuloma-
tous complications after silicone breast implants and subcuta-
neous injections have been reported in the literature.1,2 The
association between silicone and connective tissue disease-like
syndromes has also been described, but not clearly demon-
strated.3 Granulomatous disorders are common among HIV-
infected persons, and occur during various opportunistic
diseases, related to bacterial, fungal, parasitic, and tumoral
conditions.4–8
We report three cases of disseminated granulomatous disease
in HIV-infected patients, for whom the results of repeated
diagnostic investigations were consistently negative. These
immunosuppressed patients were all transvestites and had a
history of subcutaneous silicone injections and/or silicone breast
implants.* Corresponding author.
E-mail address: sylviamales@yahoo.fr (S. Males).
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2.1. Patient 1
Patient 1 was a 65-year-old man who had received multiple
subcutaneous silicone injections in both hips and buttocks. He was
admitted for an unusual asthenia and was tested HIV-positive. On
admission, physical examination was normal. Laboratory tests
disclosed elevation of total serum calcium levels (3.1 mmol/l;
normal range 2.25–2.85 mmol/l), whereas other standard biolo-
gical tests (sodium, potassium, liver enzymes, C-reactive protein)
were normal. His CD4 cell count was 112/mm3 and HIV-1 plasma
viral load 467 000 copies/ml. Further investigations were under-
taken to determine the cause of the isolated elevation of the serum
calcium level. Serum phosphorus, serum and urine protein levels
and immunoelectrophoresis were within the normal range, as well
as urine calcium and phosphorus levels. The serum level of
angiotensin-converting enzyme (ACE) was increased 1.5-fold.
Chest and hand X-rays, a technetium bone scan, abdominal
computed tomography (CT) scan, and ultrasonography were all
normal. The anti-tuberculin test was negative. No evidence of
tuberculosis or other mycobacterial infection was demonstratedses. Published by Elsevier Ltd. All rights reserved.
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normal. Highly active antiretroviral therapy (HAART) was initiated
and his immunological and virological status improved (CD4 cell
count = 450/mm3 and undetectable plasma viral load after one
year). The patient was treated with diphosphonate, resulting in a
transitory normocalcemia.
Two years later, as his serum calcium level was consistently
increased, an exploration of phosphocalcic metabolism was
undertaken and revealed a pattern of extraparathyroid hypercal-
cemia with ectopic production of calcitriol, consistent with a
granulomatous disease. A gallium-67 scan showed diffuse
heterogeneous uptake in the area of both hips, consistent with
silicone-induced granulomas.
2.2. Patient 2
Patient 2 was a 43-year-old man, who had undergone cosmetic
surgery with silicone breast implants and subcutaneous silicone
injections in the hips and buttocks. Hewas tested HIV-1 positive in
1986 and had been treated with different antiretroviral therapies
since 1996, with suboptimal compliance. Pulmonary tuberculosis
was diagnosed and treated in September 1996. Yet, after 6 months
of treatment, repeated chest CT scans displayed bilateral micro-
nodular interstitial inﬁltration, of which the origin remained
undetermined. The patient was otherwise completely asymptom-
atic. In 1999, hepatitis C was diagnosed, with a positive serumHCV
viral load. A liver biopsy showed diffuse granulomatous hepatitis
without central caseous necrosis. Numerous serial sections
revealed the presence of a single granulomatous reaction contain-
ing empty vacuoles within a sinusoid, ruling out the possibility of
lipogranuloma, which is observed around a vacuole of steatosis
inside a hepatocyte. Staining and culture of the biopsy were
negative. However, treatment against both tuberculosis and
atypical mycobacteria was given for one year without improve-
ment of the chest radiological abnormalities.
Further investigationswereundertaken todetermine the causeof
the granulomatous liver disease with probable associated pulmon-
ary involvement. Laboratory tests disclosed normal serum calcium,
phosphorus, alkaline phosphatase and aspartate aminotransferase
levels, and a 4-fold increase in gamma-glutamyl-transferase (gGT)
level. Although serumACEwas increased 4-fold, chest X-rays did not
show any abnormality consistent with sarcoidosis. Salivary gland
and bronchial biopsies were normal. However, a gallium-67 scan
showed increased uptake in the regions of the hips, breast implants,
and pulmonary parenchyma, consistent with a silicone-induced
granulomatous disease. So far, the granulomatous disease has not
been treated as the patient has remained asymptomatic.
2.3. Patient 3
Patient 3 was a 38-year-old man who had received multiple
subcutaneous silicone injections in the hips and thighs. He was
tested HIV-positive in 1997 (ﬁrst CD4 cell count 340/mm3) and had
been treated with HAART since 1999. In January 2000, liver
function tests disclosed a cholestatic hepatitis (alkaline phospha-
tase level was increased 16-fold, gGT 19-fold, and aspartate
aminotransferase level 2-fold). There was no biological or
serological evidence of an autoimmune or viral disease.
In August 2000, the patient reported unusual asthenia, weight
loss, and anorexia. Clinical examination revealed a mild fever
(38 8C), a cervical adenopathy, and hepatosplenomegaly. His CD4
cell count was 151/mm3, alkaline phosphatase level was increased
19-fold, and serum ACE was increased 2-fold. Biopsies of both the
liver and cervical adenopathy showed gigantocellular and epithe-
lioid granulomas without central necrosis. Antibiotherapy against
tuberculosis was initiated in September 2000 and extended toatypical mycobacteria in February 2001. However, repeated
investigations for an infectious origin remained negative and
treatment remained unsuccessful, with persistent fever and
increasing cholestasis.
In November 2001, treatmentwas stopped. Bronchial biopsy, as
well as gastric and ileo-colic biopsies displayed the presence of
epithelioid granulomas without central necrosis. A salivary gland
biopsy was normal. A chest CT scan revealed the presence of
signiﬁcantmediastinal lymph nodes. A gallium-67 scan showed an
isolated uptake in the liver.
In February 2002, the patient was admitted for a pulmonary
pneumocystosis and was treated with oral corticosteroids (pre-
dnisone). After one month of treatment, biological tests surpris-
ingly revealed a signiﬁcant decrease in liver enzyme levels and
cholestasis, with a signiﬁcant clinical improvement. The diagnosis
of silicone-induced granulomatous disease with hepatic, pulmon-
ary, and digestive involvement has been considered.
3. Discussion
Granulomatous disorders are common among HIV-infected
patients. They may be associated with tumoral diseases such as
lymphomas, but are more frequently associated with various
infectious diseases such as mycobacteria, histoplasmosis, crypto-
coccosis, and toxoplasmosis.4–8
In our three patients, the infectious and tumoral processes
usually associated with granulomatous disorders were ruled out.
However, two of the three patients received anti-mycobacterial
treatments, without clinical or biological improvement.
Failure of anti-mycobacterial treatments, negative results of
investigations for other causes, the results of the gallium-67 scan
showing an unusual uptake in the regions of the injection sites and
breasts implants in twopatients, and the results of the liver biopsy in
one patient argue for a silicone-induced granulomatous disorder.
Sarcoid-like pulmonary disorders have been described in HIV-
infected patients following the institution of HAART.9 After the
exclusion of infectious and environmental diseases, these dis-
orders have been related to immune reconstitution.10 However in
our three patients, the clinical and immunological histories were
not consistent with this diagnosis.
Sarcoidosis could be discussed for all the patients, especially for
patients 2 and 3, but this diagnosis remains unlikely; salivary gland
biopsies in both patients were negative. Patient 1 had no
pulmonary or hepatic localization, or mediastinal adenopathy,
and a gallium-67 scan showed isolated uptake in the area of both
hips, where silicone had been injected. Furthermore in patient 2,
the liver biopsy displayed the presence of lesions suggestive of
intravascular embolization of silicone.
Complications of silicone injections and breast implants have
been reported in the literature. They have been related to the
migration of silicone ﬂuid (after implant failure, gel leak through
the capsule, or local injections) through adjacent tissues and
lymphatic canals.2,11 Silicone elicits foreign body reactions
associated with granulomatous inﬂammation and ﬁbrosis.2 The
reactionsmay be local, loco-regional (as siliconomas), or distal.1,11–
14 In the latter case, the reactions are related to the migration of
silicone. This was observed in patient 3 who had received
subcutaneous silicone injections in the hips and thighs and
developed a granulomatous hepatitis.
Silicone produces a wide range of histological reactions in
tissues, depending on the form of the silicone and the location of
the lesion. Silicone gel and liquid in tissues usually appears in the
form of round to oval cystic spaces containing an amorphous
material, surrounded by a granulomatous reaction and a variable
degree of ﬁbrosis. Silicone may be removed during tissue
processing and may be confused with lipidic material. Scanning
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edges of vacuoles. In patient 2, the intravascular position of the
vacuoles molded within a granulomatous reaction was suggestive
of intravascular dissemination of silicone, concomitant with the
chronic granulomatous disorder. However in patients 1 and 3, the
absence of particles in the histological examination does not
deﬁnitely exclude this diagnosis, as lesions may be very subtle and
focal as shown in patient 2.
The simultaneous presence of silicone and HIV infection is
common in transgender sex workers. In HIV-infected patients
developing granulomatous disorders, an infectious or a tumoral
cause should be carefully sought. When the results of repeated
investigations remain consistently negative, silicone-induced
granulomatous disease should be considered if the patient reports
silicone injections or implants, even if this occurred many years
before. Systemic corticosteroid therapy could then be discussed. A
better knowledge of this potential association may make it
possible to avoid several aggressive investigations or the use of
extended anti-infectious treatments.
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